Literature DB >> 7925205

Dose-response relationship and time course of action of rocuronium bromide in perspective.

J Viby-Mogensen1.   

Abstract

The available evidence indicates that rocuronium is one of the least potent non-depolarizing muscle relaxants, having a clinical duration, recovery index and reversal time similar to those of atracurium and vecuronium. The onset time, however, is significantly shorter than that of currently used non-depolarizing muscle relaxants. Rocuronium seems to be potentiated by the inhalational anaesthetics to the same degree as vecuronium. This effect is clinically most significant when using a continuous infusion of rocuronium. There is no difference in potency of rocuronium between adult and elderly patients, but it is not clear yet whether the potency differs between adults and neonates, infants or children. The onset time, duration of action, and recovery index are prolonged in elderly patients and the onset time, duration of action, and recovery index are longer in infants than in children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925205

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  4 in total

1.  Efficacy of different doses of sugammadex after continuous infusion of rocuronium.

Authors:  Diego Soto Mesa; Mounir Fayad Fayad; Laura Pérez Arviza; Verónica Del Valle Ruiz; Fernando Cosío Carreño; Luis Arguelles Tamargo; Manuel Amorín Díaz; Sergio Fernández-Pello Montes
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

2.  NEUROMUSCULAR BLOCKADE AND INTUBATION CONDITIONS OF THE SINGLE BOLUS DOSE (2xED90) OF ROCURONIUM BROMIDE.

Authors:  Yudhvir Suri; N S Lamba; Rbm Krishna
Journal:  Med J Armed Forces India       Date:  2017-06-08

3.  Reversal by sugammadex.

Authors:  Pramila Bajaj
Journal:  Indian J Anaesth       Date:  2009-08

4.  A comparative study of effect of sevoflurane on intubating conditions with rocuronium in neurosurgical patients.

Authors:  Saikat Mitra; Shobha Purohit; Sonali Bhatia; Poonam Kalra; Satya Prakash Sharma
Journal:  Indian J Anaesth       Date:  2015-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.